RecruitingNot ApplicableNCT06455878

Mobile Applet for Weight Management in Obese Heart Failure Patients

The Impact of Dietary Management Applet for Weight Reduction in Obese Heart Failure Patients: a Multicenter, Single-blind Randomized Controlled Trial

Sponsor

Heart Health Research Center

Enrollment

830 participants

Start Date

Jun 6, 2024

Study Type

INTERVENTIONAL

Conditions

Heart Failure Weight Loss Overweight and Obesity Heart Failure With Reduced Ejection Fraction

Summary

The objective of this clinical trial is to investigate the effect of weight reduction through a diet management application and an intelligent weight scale on a composite cardiovascular endpoint in obese patients with heart failure. The main questions are: Does the use of a diet management APP and intelligent weight scale reduce 1-year all-cause mortality, heart failure hospitalization, and first heart failure hospital stay? Does the use of a diet management APP and intelligent weight scale improve the outcomes of assessment of heart failure frailty and quality of life for heart failure? Researchers will compare using the fully functional diet management app and intelligent weight scale to using the limitedly functional app and intelligent weight scale to see if the app works to improve heart failure conditions. Participants will: Use the diet management app at every meal and the intelligent weight scale every day for 12 months, and visit the clinic at 12 months for checkups.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether a smartphone-based weight management app can help people with heart failure and obesity manage their weight, which could reduce strain on the heart and prevent hospital admissions. **You may be eligible if...** - You are 18 or older - You have heart failure with reduced or mildly reduced pumping function (ejection fraction ≤ 50%) - Your symptoms are moderate (NYHA class II or III — breathlessness with moderate or minimal activity) - You are overweight or obese (BMI ≥ 26, or a high waist-to-hip ratio) - You own a smartphone and are able to use it - You were hospitalized for heart failure in the past 6 months **You may NOT be eligible if...** - You cannot use a smartphone or are unable to follow the diet app during the trial period - You do not meet the heart failure or weight criteria Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALFull usage of diet management app group and with the full usage of an intelligent weight scale

Subjects will use the fully functional diet management application and an intelligent weight scale with full function designed for obese heart failure patients to help them losed weight and invitigate some important composite cardiovascular endpoint.

BEHAVIORALLimited usage of diet management app group and with the limited usage of an intelligent weight scale

Subjects will use the limited function diet management application and an intelligent weight scale with limited function designed for obese heart failure patients as a comparator.

Locations(26)

Beijing Anzhen Hospital

Beijing, Beijing Municipality, China

Guangzhou Red Cross Hospital

Guangzhou, Guangdong, China

Langfang People's Hospital

Langfang, Hebei, China

Jixi City People's Hospital

Jixi, Heilongjiang, China

Luoyang No.6 People's Hospital

Luoyang, Henan, China

Ruyang County People's Hospital

Luoyang, Henan, China

Ningling County People's Hospital

Shangqiu, Henan, China

Yongcheng People's Hospital

Shangqiu, Henan, China

Shangcheng County People's Hospital

Xinyang, Henan, China

Henan Provincial Chest Hospital

Zhengzhou, Henan, China

Tongliao People's Hospital

Tongliao, Inner Mongolia, China

Xiu Yan Manchu Autonomous County Central People's Hospital

Anshan, Liaoning, China

Tiemei General Hospital of Liaoning Health Industry Group

Diaobingshancun, Liaoning, China

Shenyang Tenth Hospital

Shenyang, Liaoning, China

Pingdu People's Hospital

Pingdu, Shandong, China

Taian First Hospital

Taian, Shandong, China

Weihai Central Hospital

Weihai, Shandong, China

Qin Yuan County People's Hospital

Changzhi, Shanxi, China

Xian Red Cross Hospital

Xian, Shanxi, China

The First Affiliated Hospital of Xi'an Jiaotong University, Yulin Branch Hospital

Yulin, Shanxi, China

The First Affiliated Hospital of Xinjiang Medical University

Ürümqi, The Xinjiang Uygur Autonomous Region, China

Yuhuan Second People's Hospital

Taizhou, Zhejiang, China

Beijing Chuiyangliu Hospital

Beijing, China

Beijing Fangshan District First Hospital

Beijing, China

Emergency General Hospital

Beijing, China

Kaifeng Central Hospital

Kaifeng, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06455878

Related Trials

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

NCT06424288653 locations

Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment

NCT007393621 location

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

NCT06935370638 locations

Impact of Optimized Pacing Strategies on Clinical and Hemodynamic Outcomes in Heart Failure Patients With Pacemaker

NCT075631531 location

Dyad Plus Effectiveness/Feasibility

NCT040363311 location